QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=FE390919606FA9CDF00B0C61A4202833;jsessionid=BC2049E70A86109C63E547A350D50EA9;jsessionid=40265DE5D6899CF0E8B40BA716437A57;jsessionid=C3A278C3BC8AA1024324E901AC8C6EFF;jsessionid=3333D17D217190938D9BC9A03AF6E5CD;jsessionid=A30627EC01112B056CB530F5606F1D4A (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. A Case of Coexistent Spinocerebellar Ataxia Type 2 and Primary Progressive Multiple Sclerosis-Coinci…
4. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
5. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=FE390919606FA9CDF00B0C61A4202833;jsessionid=BC2049E70A86109C63E547A350D50EA9;jsessionid=40265DE5D6899CF0E8B40BA716437A57;jsessionid=C3A278C3BC8AA1024324E901AC8C6EFF;jsessionid=3333D17D217190938D9BC9A03AF6E5CD;jsessionid=A30627EC01112B056CB530F5606F1D4A